{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T10:33:13Z","timestamp":1771842793800,"version":"3.50.1"},"reference-count":151,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["20972079"],"award-info":[{"award-number":["20972079"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21202087"],"award-info":[{"award-number":["21202087"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002338","name":"Ministry of Education of the People's Republic of China","doi-asserted-by":"publisher","award":["B06005"],"award-info":[{"award-number":["B06005"]}],"id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2013CB911104"],"award-info":[{"award-number":["2013CB911104"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["65011171"],"award-info":[{"award-number":["65011171"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["65124002"],"award-info":[{"award-number":["65124002"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.antiviral.2012.12.005","type":"journal-article","created":{"date-parts":[[2012,12,19]],"date-time":"2012-12-19T20:14:46Z","timestamp":1355948086000},"page":"183-194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"title":["Antiviral drug discovery for the treatment of enterovirus 71 infections"],"prefix":"10.1016","volume":"97","author":[{"given":"Luqing","family":"Shang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2012.12.005_b0005","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1099\/vir.0.80164-0","article-title":"Rhinovirus 3C protease precursors 3CD and 3CD\u2032 localize to the nuclei of infected cells","volume":"85","author":"Amineva","year":"2004","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0010","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1099\/vir.0.2008\/002915-0","article-title":"Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus71 infectivity","volume":"89","author":"Arita","year":"2008","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0015","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1099\/vir.0.012096-0","article-title":"Cellular kinase inhibitors that suppress enterovirus replication have a conserved target in viral protein 3A similar to that of enviroxime","volume":"90","author":"Arita","year":"2009","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0020","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1099\/vir.0.023374-0","article-title":"A bifunctional anti-enterovirus compound that inhibits replication and the early stage of enterovirus 71 infection","volume":"91","author":"Arita","year":"2010","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0025","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.327545","article-title":"A bactericidal effect for human lactoferrin","volume":"197","author":"Arnold","year":"1977","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2012.12.005_b0030","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1128\/AAC.48.5.1766-1772.2004","article-title":"In vitro activity of expanded-spectrum pyridazinyl oxime ethers related to pirodavir: novel capsid-binding in hibitors with potent antipicornavirus activity","volume":"48","author":"Barnard","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2012.12.005_b0765","series-title":"Molecular Biology of Picornaviruses","first-page":"461","article-title":"Poliovirus RNA replication and genetic complementation in cell-free reactions","author":"Barton","year":"2002"},{"key":"10.1016\/j.antiviral.2012.12.005_b0040","doi-asserted-by":"crossref","first-page":"7872","DOI":"10.1073\/pnas.85.21.7872","article-title":"Viral cysteine proteases are homologous to the trypsin-like family of serine proteases: structural and functional implications","volume":"85","author":"Bazan","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2012.12.005_b0045","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nature04397","article-title":"Organelle identity and the signposts for membrane traffic","volume":"438","author":"Behnia","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2012.12.005_b0050","doi-asserted-by":"crossref","first-page":"7207","DOI":"10.1128\/JVI.79.11.7207-7216.2005","article-title":"Poliovirus proteins induce membrane association of GTPase ADP-ribosylation factor","volume":"79","author":"Belov","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0060","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/viro.1999.9968","article-title":"Crystal structure of an inhibitor complex of the 3C proteinase from hepatitis A virus (HAV) and implications for the polyprotein processing in HAV","volume":"265","author":"Bergmann","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0065","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1128\/AAC.49.2.619-626.2005","article-title":"Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor","volume":"49","author":"Binford","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2012.12.005_b0070","doi-asserted-by":"crossref","first-page":"11520","DOI":"10.1074\/jbc.M413254200","article-title":"Crystal structure of foot-and-mouth disease virus 3C protease: new insights into catalytic mechanism and cleavage specificity","volume":"280","author":"Birtley","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2012.12.005_b0075","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0168-1702(95)00087-9","article-title":"Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus","volume":"39","author":"Brown","year":"1995","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2012.12.005_b0080","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.meegid.2009.05.010","article-title":"Phylogenetic designation of enterovirus 71 genotypes and subgenotypes using complete genome sequences","volume":"10","author":"Chan","year":"2010","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0085","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1021\/jm050033v","article-title":"Design, synthesis, and antipicornavirus activity of 1-[5-(4-arylphenoxy)alkyl]-3-pyridin-4-ylimidazolidin-2-one derivatives","volume":"48","author":"Chang","year":"2005","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.antiviral.2012.12.005_b0770","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3390\/v4040539","article-title":"Daphne Genkwa sieb. Et zucc. Water-soluble extracts act on enterovirus 71 by inhibiting viral entry","volume":"4","author":"Chang","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2012.12.005_b0095","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.vaccine.2011.11.087","article-title":"Selection and characterization of vaccine strain for Enterovirus 71 vaccine development","volume":"30","author":"Chang","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2012.12.005_b0100","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00006454-200404000-00010","article-title":"Outcome of enterovirus 71 infections with or without stage-based management: 1998 to 2002","volume":"23","author":"Chang","year":"2004","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.antiviral.2012.12.005_b0105","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1056\/NEJMoa065954","article-title":"Neurodevelopment and cognition in children after enterovirus 71 infection","volume":"356","author":"Chang","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.antiviral.2012.12.005_b0110","doi-asserted-by":"crossref","first-page":"6406","DOI":"10.1074\/jbc.M111.301622","article-title":"Molecular determinants of enterovirus 71 viral entry: cleft around GLN-172 on VP1 protein interacts with variable region on scavenge receptor B2","volume":"287","author":"Chen","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2012.12.005_b0115","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11373-007-9228-5","article-title":"Antiviral activity of pyridylimidazolidinones against enterovirus 71 variants","volume":"15","author":"Chen","year":"2008","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.antiviral.2012.12.005_b0120","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1128\/AAC.00101-09","article-title":"Novel antiviral agent DTriP-22 targets RNA-dependent RNA polymerase of enterovirus 71","volume":"53","author":"Chen","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2012.12.005_b0125","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1016\/j.bmcl.2004.07.084","article-title":"Synthesis and antienteroviral activity of a series of novel, oxime ether-containing pyridyl imidazolidinones","volume":"14","author":"Chern","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2012.12.005_b0130","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1440-1681.2005.04270.x","article-title":"Antiviral activities of extracts and selected pure constituents of Ocimum basilicum","volume":"32","author":"Chiang","year":"2005","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0135","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.micinf.2006.01.021","article-title":"Protection of neonatal mice from lethal enterovirus 71 infection by maternal immunization with attenuated Salmonella enterica serovar Typhimurium expressing VP1 of enterovirus 71","volume":"8","author":"Chiu","year":"2006","journal-title":"Microbes Infect."},{"issue":"2","key":"10.1016\/j.antiviral.2012.12.005_b0140","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.antiviral.2012.05.009","article-title":"Prevention of human enterovirus 71 infection by kappa carrageenan","volume":"95","author":"Chiu","year":"2012","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2012.12.005_b0145","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.phymed.2008.10.012","article-title":"Antiviral activity of raoulic acid from Raoulia australis against picornaviruses","volume":"16","author":"Choi","year":"2009","journal-title":"Phytomedicine"},{"issue":"4","key":"10.1016\/j.antiviral.2012.12.005_b0150","doi-asserted-by":"crossref","first-page":"e34834","DOI":"10.1371\/journal.pone.0034834","article-title":"Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates","volume":"7","author":"Chou","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2012.12.005_b0155","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.vaccine.2008.01.058","article-title":"Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge","volume":"26","author":"Chung","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2012.12.005_b0160","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1002\/j.1460-2075.1991.tb07844.x","article-title":"Poliovirus proteinase 3C converts an active form of transcription factor IIIC to an inactive form: a mechanism for inhibition of host cell polymerase III transcription by poliovirus","volume":"10","author":"Clark","year":"1991","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2012.12.005_b0165","first-page":"1232","article-title":"Direct cleavage of human TATA-binding protein by poliovirus protease 3C in vivo and in vitro","volume":"13","author":"Clark","year":"1993","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0170","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1177\/095632029800900607","article-title":"Anti-picornavirus activity of synthetic flavon-3-yl esters","volume":"9","author":"Conti","year":"1998","journal-title":"Antiviral Chem. Chemother."},{"key":"10.1016\/j.antiviral.2012.12.005_b0175","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jmb.2011.03.007","article-title":"Crystal structure of human enterovirus 71 3C protease","volume":"408","author":"Cui","year":"2011","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0180","first-page":"258","article-title":"New developments in anti-HIV chemotherapy","volume":"1587","author":"DeClercq","year":"2002","journal-title":"Biochem. Biophys. Acta"},{"key":"10.1016\/j.antiviral.2012.12.005_b0185","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1128\/JVI.02076-07","article-title":"Functional analysis of picornavirus 2B proteins: effects on calcium homeostasis and intracellular protein trafficking","volume":"82","author":"DeJong","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0190","doi-asserted-by":"crossref","first-page":"19924","DOI":"10.1074\/jbc.M314094200","article-title":"Mutational analysis of different regions in the coxsackievirus 2B protein: requirements for homo-multimerization, membrane permeabilization, subcellular localization, andvirus replication","volume":"279","author":"DeJong","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2012.12.005_b0195","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1099\/0022-1317-83-4-783","article-title":"Multimerization reactions of coxsackievirus proteins 2B, 2C and 2BC: a mammalian two-hybrid analysis","volume":"83","author":"DeJong","year":"2002","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0200","doi-asserted-by":"crossref","first-page":"14144","DOI":"10.1074\/jbc.M511766200","article-title":"The coxsackievirus 2B protein increases efflux of ions from the endoplasmic reticulum and Golgi, thereby inhibiting protein trafficking through the Golgi","volume":"281","author":"DeJong","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2012.12.005_b0205","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1074\/jbc.M207745200","article-title":"Determinants for membrane association and permeabilization of the coxsackievirus 2B protein and the identification of the Golgi complex as the target organelle","volume":"278","author":"DeJong","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2012.12.005_b0210","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1423-0127-19-73","article-title":"The highly conserved 5\u2032 untranslated region as an effective target towards the inhibition of Enterovirus 71 replication by unmodified and appropriate 2\u2032-modified siRNAs","volume":"19","author":"Deng","year":"2012","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.antiviral.2012.12.005_b0215","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3201\/eid1404.070439","article-title":"Potential use of antiviral agents in polioeradication","volume":"14","author":"DePalma","year":"2008","journal-title":"Emer. Infect. Dis."},{"key":"10.1016\/j.antiviral.2012.12.005_b0220","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1128\/AAC.00934-08","article-title":"Mutations in the nonstructural protein 3A confer resistance to the novel enterovirus replication inhibitor TTP-8307","volume":"53","author":"DePalma","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2012.12.005_b0225","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/med.20125","article-title":"Selective inhibitors of picornavirus replication","volume":"28","author":"DePalma","year":"2008","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.antiviral.2012.12.005_b0775","series-title":"Introduction to Modern Virology","first-page":"34","article-title":"The structure of virus","author":"Dimmock","year":"2001"},{"key":"10.1016\/j.antiviral.2012.12.005_b0235","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1021\/jm00150a025","article-title":"[[(4,5-Dihydro-2-oxazolyl)phenoxy]alkyl]isoxazoles. Inhibitors of picornavirus uncoating","volume":"28","author":"Diana","year":"1985","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2012.12.005_b0240","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/j.1460-2075.1995.tb07071.x","article-title":"Inhibition of cellular protein secretion by poliovirus proteins 2B and 3A","volume":"14","author":"Doedens","year":"1995","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2012.12.005_b0245","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1021\/jm9805384","article-title":"Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as l-glutamine replacements","volume":"42","author":"Dragovich","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2012.12.005_b0250","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1021\/jm980068d","article-title":"Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors.1. Michael acceptor structure\u2013activity studies","volume":"41","author":"Dragovich","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2012.12.005_b0255","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1128\/jvi.64.2.748-756.1990","article-title":"Foot-and-mouth disease virus protease 3C induces specific proteolytic cleavage of host cell histone H3","volume":"64","author":"Falk","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0260","doi-asserted-by":"crossref","unstructured":"Falah, N., et al., 2012. Blocking human enterovirus 71 replication by targeting viral 2A protease. J. Antimicrob. Chemother. [Epub ahead of print].","DOI":"10.1093\/jac\/dks304"},{"key":"10.1016\/j.antiviral.2012.12.005_b0265","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.micinf.2007.06.002","article-title":"Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide","volume":"9","author":"Foo","year":"2007","journal-title":"Microbes Infect."},{"key":"10.1016\/j.antiviral.2012.12.005_b0270","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0166-3542(95)00088-4","article-title":"Effect of chloro-, cyano-, and amidino-substituted flavanoids on enterovirus infection in vitro","volume":"27","author":"Genovese","year":"1995","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2012.12.005_b0275","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nature00873","article-title":"Short interfering RNA confers intracellular antiviral immunity in human cells","volume":"418","author":"Gitlin","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2012.12.005_b0280","doi-asserted-by":"crossref","first-page":"7481","DOI":"10.1128\/jvi.66.12.7481-7489.1992","article-title":"Purification and characterization of poliovirus polypeptide 3CD, a proteinase and a precursor for RNA polymerase","volume":"66","author":"Harris","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0285","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1128\/jvi.70.7.4854-4857.1996","article-title":"Sequence determinants of 3A-mediated resistance to enviroxime in rhinoviruses and enteroviruses","volume":"70","author":"Heinz","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0290","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1128\/jvi.66.6.3330-3338.1992","article-title":"Determinants of substrate recognition by poliovirus 2A proteinase","volume":"66","author":"Hellen","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0295","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1126\/science.2994218","article-title":"Three-dimensional structure of poliovirus at 2.9 A resolution","volume":"229","author":"Hogle","year":"1985","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.antiviral.2012.12.005_b0300","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/jac\/dkp502","article-title":"Inhibition of enterovirus 71 replication and the viral 3D polymerase by aurintricarboxylic acid","volume":"65","author":"Hung","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"issue":"12","key":"10.1016\/j.antiviral.2012.12.005_b0305","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/infdis\/jir174","article-title":"Synergistic inhibition of enterovirus 71 replication by interferon and rupintrivir","volume":"203","author":"Hung","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.antiviral.2012.12.005_b0310","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.virol.2011.10.015","article-title":"Mutations in VP2 and VP1 capsid proteins increase infectivity and mouse lethality of enterovirus 71 by virus binding and RNA accumulation enhancement","volume":"422","author":"Huang","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2012.12.005_b0315","doi-asserted-by":"crossref","unstructured":"Jiang, H., et al., 2011. Biochemical characterization of enterovirus 71 3D RNA polymerase. 1809, 211\u2013219.","DOI":"10.1016\/j.bbagrm.2011.01.001"},{"key":"10.1016\/j.antiviral.2012.12.005_b0320","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1128\/JVI.73.1.718-727.1999","article-title":"Cleavage of poly(A)-binding protein by enterovirus proteases concurrent with inhibition of translation in vitro","volume":"73","author":"Joachims","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0325","doi-asserted-by":"crossref","first-page":"5847","DOI":"10.1128\/JVI.01514-07","article-title":"Poliovirus 2A(Pro) increases viral mRNA and polysome stability coordinately in time with cleavage of eIF4G","volume":"82","author":"Kempf","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0330","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jviromet.2012.06.025","article-title":"Development of murine monoclonal antibodies with potent neutralization effects on enterovirus 71","volume":"186","author":"Ku","year":"2012","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.antiviral.2012.12.005_b0335","series-title":"Molecular Biology of Picornaviruses","first-page":"301","article-title":"Picornavirus proteinase-mediated shutoff of host cell translation: direct cleavage of a cellular initiation factor","author":"Kuechler","year":"2002"},{"key":"10.1016\/j.antiviral.2012.12.005_b0340","doi-asserted-by":"crossref","first-page":"7388","DOI":"10.1016\/j.bmc.2008.06.015","article-title":"Design, synthesis, and evaluation of 3C protease inhibitors as anti-enterovirus 71 agents","volume":"16","author":"Kuo","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.antiviral.2012.12.005_b0345","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1128\/jvi.76.5.2062-2074.2002","article-title":"Efficient cleavage of ribosome-associated poly(A)-binding protein by enterovirus 3C protease","volume":"76","author":"Kuyumcu-Martinez","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0350","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1128\/MCB.24.4.1779-1790.2004","article-title":"Cleavage of poly(A)-binding protein by poliovirus 3C protease inhibits host cell translation: a novel mechanism for host translation shutoff","volume":"24","author":"Kuyumcu-Martinez","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0355","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0003-2697(03)00053-8","article-title":"Development of a cell-based assay for monitoring specific hepatitis C virus NS3\/4A protease activity in mammalian cells","volume":"316","author":"Lee","year":"2003","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.antiviral.2012.12.005_b0360","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ab.2007.12.019","article-title":"A mammalian cell-based reverse two-hybrid system for functional analysis of 3C viral protease of human enterovirus 71","volume":"375","author":"Lee","year":"2008","journal-title":"Anal. Biochem."},{"issue":"22","key":"10.1016\/j.antiviral.2012.12.005_b0365","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1016\/j.vaccine.2012.03.010","article-title":"Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: a randomized, placebo-controlled, double-blind, Phase I clinical trial","volume":"30","author":"Li","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2012.12.005_b0370","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1099\/0022-1317-82-2-397","article-title":"The C-terminal residues of poliovirus proteinase 2A(pro) are critical for viral RNA replication but not for cis- or trans-cleavage","volume":"82","author":"Li","year":"2001","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0375","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1086\/527326","article-title":"Ribavirin reduces mortality in enterovirus 71-infected mice by decreasing viral replication","volume":"197","author":"Li","year":"2008","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.antiviral.2012.12.005_b0380","doi-asserted-by":"crossref","first-page":"e29751","DOI":"10.1371\/journal.pone.0029751","article-title":"Characterization of an isotype-dependent monoclonal antibody against linear neutralizing epitope effective for prophylaxis of enterovirus 71 infection","volume":"7","author":"Lim","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2012.12.005_b0385","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1423-0127-16-103","article-title":"Viral and host proteins involved in picornavirus life cycle","volume":"16","author":"Lin","year":"2009","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.antiviral.2012.12.005_b0390","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1086\/343809","article-title":"Lactoferrin inhibits enterovirus 71 infection of human embryonal rhabdomyosarcoma cells in vitro","volume":"186","author":"Lin","year":"2002","journal-title":"J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.antiviral.2012.12.005_b0395","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.vaccine.2011.12.081","article-title":"Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles","volume":"30","author":"Lin","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2012.12.005_b0400","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3181\/0903-RM-116","article-title":"Enterovirus 71 infection of human dendritic cells","volume":"234","author":"Lin","year":"2009","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.antiviral.2012.12.005_b0405","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00705-011-1198-2","article-title":"Transgenic expression of human P-selectin glycoprotein ligand-1 is not sufficient for enterovirus 71 infection in mice","volume":"157","author":"Liu","year":"2012","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0410","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1186\/1743-422X-8-483","article-title":"Lycorine reduces mortality of human enterovirus 71-infected mice by inhibiting virus replication","volume":"8","author":"Liu","year":"2011","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2012.12.005_b0415","doi-asserted-by":"crossref","first-page":"7444","DOI":"10.1016\/j.vaccine.2010.08.080","article-title":"Combined peptides of human enterovirus 71 protect against virus infection in mice","volume":"28","author":"Liu","year":"2010","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.antiviral.2012.12.005_b0420","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1099\/vir.0.81195-0","article-title":"Type I interferons protect mice against enterovirus 71 infection","volume":"286","author":"Liu","year":"2005","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0425","doi-asserted-by":"crossref","first-page":"10319","DOI":"10.1128\/JVI.00787-11","article-title":"Enterovirus 71 and Coxsackievirus A16 3C proteases: binding to Rupintrivir and their substrates and anti-hand, foot, and mouth disease virus drug design","volume":"85","author":"Lu","year":"2011","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.antiviral.2012.12.005_b0430","first-page":"51","article-title":"Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1","volume":"16","author":"Lu","year":"2011","journal-title":"Antiviral Ther."},{"key":"10.1016\/j.antiviral.2012.12.005_b0435","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.bbrc.2004.10.062","article-title":"Selective inhibition of enterovirus 71 replication by short hairpin RNAs","volume":"325","author":"Lu","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2012.12.005_b0440","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.3748\/wjg.v9.i11.2474","article-title":"Establishment of a cell-based assay system for hepatitis C virus serine protease and its primary applications","volume":"9","author":"Mao","year":"2003","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0445","doi-asserted-by":"crossref","first-page":"e46043","DOI":"10.1371\/journal.pone.0046043","article-title":"Comparative analysis of the immunogenicity and protective effects of inactivated EV71 vaccines in mice","volume":"7","author":"Mao","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2012.12.005_b0450","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1128\/JVI.02306-06","article-title":"Crystal structure of poliovirus 3CD protein: virally encoded protease and precursor to the RNA-dependent RNA polymerase","volume":"81","author":"Marcotte","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0455","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/0092-8674(94)90059-0","article-title":"Structure of human rhinovirus 3C protease reveals a trypsin-like polypeptide fold, RNA-binding site, and means for cleaving precursor polyprotein","volume":"77","author":"Matthews","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2012.12.005_b0460","doi-asserted-by":"crossref","first-page":"668","DOI":"10.4161\/hv.19521","article-title":"Tolerability and immunogenicity of an inactivated enterovirus 71 vaccine in Chinese healthy and adults and children: an open label, phase 1 clinical trial","volume":"8","author":"Meng","year":"2012","journal-title":"Human Vaccine Immunother."},{"issue":"3","key":"10.1016\/j.antiviral.2012.12.005_b0465","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1006\/jmbi.1997.1306","article-title":"Refined X-ray crystallographic structure of the poliovirus 3C gene product","volume":"27","author":"Mosimann","year":"1997","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0470","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/30529","article-title":"Proteinprimed RNA synthesis by purified poliovirus RNA polymerase","volume":"393","author":"Paul","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2012.12.005_b0475","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1128\/JVI.77.2.891-904.2003","article-title":"Biochemical and genetic studies of the VPg uridylylation reaction catalyzed by the RNA polymerase of poliovirus","volume":"77","author":"Paul","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0480","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1128\/AAC.43.9.2109","article-title":"Activity of Pleconaril against Enteroviruses","volume":"43","author":"Pevear","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2012.12.005_b0485","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.antiviral.2003.08.005","article-title":"Small interfering RNA molecules as potential anti-human rhinovirus agents: in vitro potency, specificity, and mechanism","volume":"61","author":"Phipps","year":"2004","journal-title":"Antiviral Res."},{"issue":"5","key":"10.1016\/j.antiviral.2012.12.005_b0490","first-page":"e34589","article-title":"Crystal structure of human enterovirus 71","volume":"7","author":"Plevka","year":"2012","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.antiviral.2012.12.005_b0495","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.virusres.2012.06.025","article-title":"In vitro evaluation of the antiviral activity of heparin sulfate mimetic compounds against Enterovirus 71","volume":"169","author":"Pourianfar","year":"2012","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2012.12.005_b0500","unstructured":"Prendergast, P.T., 2001. Use of flavones, coumarins, and related compounds to treat infections. World (PTC) Patent WO-0103681."},{"key":"10.1016\/j.antiviral.2012.12.005_b0780","series-title":"Fields virology","first-page":"685","article-title":"Picornaviridae: the viruses and their replication","author":"Racaniello","year":"2001"},{"key":"10.1016\/j.antiviral.2012.12.005_b0785","series-title":"Fields Virology","first-page":"796","article-title":"Picornaviridae: the viruses and their replication","author":"Racaniello","year":"2007"},{"key":"10.1016\/j.antiviral.2012.12.005_b0515","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0166-3542(01)00206-6","article-title":"Treatment of picornavirus infections","volume":"53","author":"Rotbart","year":"2002","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2012.12.005_b0520","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1099\/0022-1317-78-4-699","article-title":"Virus-encoded proteinases of the picornavirus super-group","volume":"78","author":"Ryan","year":"1997","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0790","series-title":"Molecular Biology of Picornaviruses","author":"Semler","year":"2002"},{"key":"10.1016\/j.antiviral.2012.12.005_b0530","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.virol.2003.10.020","article-title":"Nuclear entry of poliovirus protease-polymerase precursor 3CD: implications for host cell transcription shut-off","volume":"320","author":"Sharma","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2012.12.005_b0535","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1021\/jm010536a","article-title":"Design, synthesis, structure\u2013activity relationship of pyridyl imidazolidinones: a novel class of potent and selective human enterovirus 71 inhibitors","volume":"45","author":"Shia","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2012.12.005_b0540","unstructured":"Shia, K.S., et al., 2003. Imidazolidinone compounds. US Patent US-0087936."},{"key":"10.1016\/j.antiviral.2012.12.005_b0545","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/jmv.10363","article-title":"Inhibition of enterovirus71-induced apoptosis by allophycocyanin isolated from a blue-green alga Spirulina platensis","volume":"70","author":"Shih","year":"2003","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0550","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/med.10067","article-title":"Selective human enterovirus and rhinovirus inhibitors: an overview of capsid-binding and protease-inhibiting molecules","volume":"24","author":"Shih","year":"2004","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.antiviral.2012.12.005_b0555","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/j.bmcl.2004.02.092","article-title":"Design, synthesis, and structure\u2013activity relationships of pyrazolo[3,4-d]pyrimidines: a novel class of potent enterovirus inhibitors","volume":"14","author":"Shih","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"9","key":"10.1016\/j.antiviral.2012.12.005_b0560","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1128\/AAC.48.9.3523-3529.2004","article-title":"Mutation in enterovirus 71 capsid protein VP1 confers resistance to the inhibitory effects of pyridyl imidazolidinone","volume":"48","author":"Shih","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2012.12.005_b0565","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/13550280701798980","article-title":"Viral protein synthesis is required for enterovirus71 to induce apoptosis in human glioblastoma cells","volume":"14","author":"Shih","year":"2008","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0570","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/jmv.20668","article-title":"Recombinant new castle disease virus capsids displaying enterovirus 71 VP1 fragment induce a strong immune response in rabbits","volume":"78","author":"Sivasamugham","year":"2006","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0575","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0042-6822(89)90042-1","article-title":"Polypeptide 2A of human rhinovirus type 2: identification as a protease and characterization by mutational analysis","volume":"169","author":"Sommergruber","year":"1989","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2012.12.005_b0580","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/1471-2180-12-162","article-title":"Cell surface sialylation affects binding of enterovirus 71 to rhabdomyosarcoma and neuroblastoma cells","volume":"12","author":"Su","year":"2012","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0585","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00705-007-0941-1","article-title":"High-titred neutralizing antibodies to human enterovirus preferentially bind to the N-terminal portion of the capsid protein VP1","volume":"152","author":"Tan","year":"2007","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0590","doi-asserted-by":"crossref","first-page":"e34589","DOI":"10.1371\/journal.pone.0034589","article-title":"Inhibition of enterovirus 71 (EV-71) infections by a novel antiviral peptide derived from EV-71 capsid protein VP1","volume":"7","author":"Tan","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2012.12.005_b0595","doi-asserted-by":"crossref","first-page":"e25662","DOI":"10.1371\/journal.pone.0025662","article-title":"The persistent circulation of Enterovirus 71 in People\u2019s Republic of China: causing emerging nationwide epidemics since 2008","volume":"6","author":"Tan","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2012.12.005_b0600","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1074\/jbc.M611145200","article-title":"Reticulon 3 binds the 2C protein of enterovirus 71 and is required for viral replication","volume":"282","author":"Tang","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2012.12.005_b0605","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/0092-8674(86)90790-7","article-title":"A second virus-encoded proteinase involved in proteolytic processing of poliovirus polyprotein","volume":"45","author":"Toyoda","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2012.12.005_b0610","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1128\/AAC.00841-08","article-title":"Real-time monitoring of human enterovirus (HEV)-infected cells and anti-HEV 3C protease potency by fluorescence resonance energy transfer","volume":"53","author":"Tsai","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2012.12.005_b0795","first-page":"5","article-title":"DNA vaccine constructs against enterovirus 71 elicit immune response in mice","author":"Tung","year":"2007","journal-title":"Genet. Vaccines Ther."},{"key":"10.1016\/j.antiviral.2012.12.005_b0620","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.3390\/molecules13112758","article-title":"Polyanionic drugs and viral oncogenesis: a novel approach to control infection, tumor-associated inflammation and angiogenesis","volume":"13","author":"Urbinati","year":"2008","journal-title":"Molecules"},{"key":"10.1016\/j.antiviral.2012.12.005_b0625","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1128\/jvi.70.6.3876-3886.1996","article-title":"Coxsackie B3 virus protein 2B contains cationic amphipathic helix that is required for viral RNA replication","volume":"70","author":"Van Kuppeveld","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0630","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1093\/emboj\/16.12.3519","article-title":"Coxsackievirus protein 2B modifies endoplasmic reticulum membrane and plasma membrane permeability and facilitates virus release","volume":"16","author":"Van Kuppeveld","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2012.12.005_b0635","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.antiviral.2011.11.001","article-title":"MEK1\u2013ERKs signal cascade is required for the replication of Enterovirus 71 (EV71)","volume":"93","author":"Wang","year":"2012","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2012.12.005_b0640","doi-asserted-by":"crossref","first-page":"10021","DOI":"10.1128\/JVI.05107-11","article-title":"Crystal structure of enterovirus 71 3C protease complexed with rupintrivir reveals the roles of catalytically important residues","volume":"85","author":"Wang","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0645","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nsmb.2255","article-title":"A sensor\u2013adaptor mechanism for enterovirus uncoating from structures of EV71","volume":"19","author":"Wang","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0650","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1021\/jm0202876","article-title":"An orally bioavailable oxime ether capsid binder with potent activity against human rhinovirus","volume":"46","author":"Watson","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2012.12.005_b0655","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1006\/viro.2001.1215","article-title":"Poliovirus 3C protease-mediated degradation of transcriptional activator p53 requires a cellular activity","volume":"291","author":"Weidman","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2012.12.005_b0660","doi-asserted-by":"crossref","first-page":"e1000593","DOI":"10.1371\/journal.ppat.1000593","article-title":"Enterovirus 71 3C protease cleaves a novel target CstF-64 and inhibits cellular polyadenylation","volume":"5","author":"Weng","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2012.12.005_b0665","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.antiviral.2005.03.005","article-title":"Lactoferrin inhibits enterovirus 71 infection by binding to VP1 protein and host cells","volume":"67","author":"Weng","year":"2005","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2012.12.005_b0670","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0264-410X(01)00385-1","article-title":"Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus","volume":"20","author":"Wu","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2012.12.005_b0675","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s13238-010-0061-7","article-title":"Structures of EV71 RNA-dependent RNA polymerase in complex with substrate and analogue provide a drug target against the hand\u2013foot-and-mouth diseasepandemic in China","volume":"1","author":"Wu","year":"2010","journal-title":"Protein Cell"},{"key":"10.1016\/j.antiviral.2012.12.005_b0680","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jviromet.2009.04.002","article-title":"Identification of small interfering RNAs which inhibit the replication of several Enterovirus 71 strains in China","volume":"159","author":"Wu","year":"2009","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.antiviral.2012.12.005_b0685","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/cr.2011.112","article-title":"DIDS blocks a chloride-dependent current that is mediated by the 2B protein of enterovirus 71","volume":"21","author":"Xie","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.antiviral.2012.12.005_b0690","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/j.bmc.2011.03.007","article-title":"Inhibitory properties of 2-substituent-1H-benzimidazole-4-carboxamide derivatives against enteroviruses","volume":"19","author":"Xue","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.antiviral.2012.12.005_b0695","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1128\/jvi.71.9.6881-6886.1997","article-title":"Poliovirus-encoded protease 2APro cleaves the TATA-binding protein but does not inhibit host cell RNA polymerase II transcription in vitro","volume":"71","author":"Yalamanchili","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0700","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1128\/jvi.71.2.1220-1226.1997","article-title":"Inhibition of host cell transcription by poliovirus: cleavage of transcription factor CREB by poliovirus-encoded protease 3Cpro","volume":"71","author":"Yalamanchili","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0800","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1006\/viro.1997.8862","article-title":"Cleavage of transcriptional activator Oct-1 by poliovirus encoded protease 3Cpro","volume":"239","author":"Yalamanchili","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2012.12.005_b0710","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nm.1992","article-title":"Scavenger receptor B2 is a cellular receptor for enterovirus 71","volume":"15","author":"Yamayoshi","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2012.12.005_b0715","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1743-422X-6-141","article-title":"Sialylated glycans as receptor and inhibitor of enterovirus71 infection to DLD-1 intestinal cells","volume":"6","author":"Yang","year":"2009","journal-title":"Virol. J."},{"issue":"9","key":"10.1016\/j.antiviral.2012.12.005_b0720","doi-asserted-by":"crossref","first-page":"10370","DOI":"10.3390\/molecules170910370","article-title":"Antiviral effect of matrine against human enterovirus 71","volume":"17","author":"Yang","year":"2012","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.antiviral.2012.12.005_b0725","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3851\/IMP1720","article-title":"Potent inhibition of human enterovirus 71 replication by type I interferon subtypes","volume":"16","author":"Yi","year":"2011","journal-title":"Antiviral Ther."},{"key":"10.1016\/j.antiviral.2012.12.005_b0730","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/nm.1961","article-title":"Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71","volume":"15","author":"Yorihiro","year":"2009","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.antiviral.2012.12.005_b0735","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00705-011-1222-6","article-title":"In vitro and in vivo evaluation of ribavirin and pleconaril antiviral activity against enterovirus 71 infection","volume":"157","author":"Zhang","year":"2012","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0740","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3748\/wjg.v16.i2.201","article-title":"Rupintrivir is a promising candidate for the treatment severe cases of Enterovirus 71 infection","volume":"16","author":"Zhang","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0745","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1743-422X-7-94","article-title":"An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of Hand Foot and Mouth Disease in Fuyang city of China","volume":"7","author":"Zhang","year":"2010","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2012.12.005_b0750","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.4049\/jimmunol.1100285","article-title":"Enterovirus 71 2C protein inhibits INF-\u03b1-mediated activation of NF-kB by suppressing IkB kinase \u03b2 phosphorylation","volume":"187","author":"Zheng","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2012.12.005_b0755","first-page":"375","article-title":"Isolation of enterovirus type 71 from the vesicle fluid of an adult patient with hand\u2013foot\u2013mouth disease in China","volume":"4","author":"Zheng","year":"1989","journal-title":"Virologica Sinica"},{"key":"10.1016\/j.antiviral.2012.12.005_b0760","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ejps.2011.08.030","article-title":"Inhibition of enterovirus 71 replication by chrysosplenetin and penduletin","volume":"44","author":"Zhu","year":"2011","journal-title":"Eur. J. Pharm. Sci."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354212002859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354212002859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:25:58Z","timestamp":1759062358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354212002859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":151,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0166354212002859"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2012.12.005","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiviral drug discovery for the treatment of enterovirus 71 infections","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2012.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}